Frank Rimerman Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,138
Closed -$402K 119
2022
Q1
$402K Hold
2,138
0.13% 89
2021
Q4
$566K Buy
2,138
+386
+22% +$104K 0.19% 71
2021
Q3
$506K Buy
+1,752
New +$449K 0.2% 64

Other funds holding RGEN

Frank Rimerman Advisors's RGEN Position: Q2 2022 in Review

Frank Rimerman Advisors sold out of Repligen (RGEN) in Q2 2022, closing a stake of 2,138 shares — an estimated $402K sold.

Frank Rimerman Advisors first reported a position in RGEN in Q3 2021 and held it in 3 quarters. The position peaked at $566K in Q4 2021. 404 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.

  • Frank Rimerman Advisors reported no remaining Repligen position as of Q2 2022 after selling out during the quarter.
  • Frank Rimerman Advisors sold 2,138 Repligen shares in Q2 2022, an estimated $402K.
  • Frank Rimerman Advisors first reported a position in Repligen in Q3 2021 and held it in 3 quarters.
  • Frank Rimerman Advisors's Repligen position peaked at $566K in Q4 2021.
  • 404 funds tracked by Wall St. Rank held Repligen as of Q2 2022.

Based on Frank Rimerman Advisors's 13F filing for Q2 2022, filed 7 Sep 2023.